Quantitative analysis of mitragynine in human urine by high performance liquid chromatography-tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 877, Issue 24, 2009, Pages 2499-2505

  Lu, Shijun ^a   Tran, Buu N ^a   Nelsen, Jamie L ^b   Aldous, Kenneth M ^a  

^a WADSWORTH CENTER   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Forensic; HPLC MS MS; Kratom; Mitragynine; Urine drug test

Indexed keywords

FORENSIC; HPLC-MS/MS; KRATOM; MITRAGYNINE; URINE DRUG TEST;

BODY FLUIDS; CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; ETHERS; HIGH PRESSURE LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETERS; MASS SPECTROMETRY; METAL RECOVERY; QUALITY ASSURANCE; QUALITY CONTROL; QUALITY FUNCTION DEPLOYMENT; STANDARDIZATION; TOTAL QUALITY MANAGEMENT;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

AJMALICINE; MITRAGYNINE; TERT BUTYL METHYL ETHER;

ARTICLE; CALIBRATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG ABUSE; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID LIQUID EXTRACTION; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; QUALITY CONTROL; QUANTITATIVE ANALYSIS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; SECOLOGANIN TRYPTAMINE ALKALOIDS; STREET DRUGS; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

MITRAGYNA SPECIOSA;

EID: 67650741187     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2009.06.024     Document Type: Article

References (19)

1. Shellard E. Bull. Narc. 26 (1974) 41
2. Thongpradichote S., Matsumoto K., Tohda M., Takayama H., Aimi N., Sakai S., and Watanabe H. Life Sci. 62 (1998) 1371
3. Babu K.M., McCurdy C.R., and Boyer E.W. Clin. Toxicol. (Phila.) 46 (2008) 146
4. Takayama H. Chem. Pharm. Bull. (Tokyo) 52 (2004) 359
5. Zacharias D.E., Rosenstein R.D., and Jeffrey G.A. Acta Cryst. 18 (1965) 1039
6. Takayama H., Maeda M., Ohbayashi S., Kitajima M., Sakai S., and Aimi N. Tetrahedron Lett. 36 (1995) 9337
7. Matsumoto K., Mizowaki M., Suchitra T., Takayama H., Sakai S., Aimi N., and Watanabe H. Life Sci. 59 (1996) 1149
8. Yamamoto L.T., Horie S., Takayama H., Aimi N., Sakai S., Yano S., Shan J., Pang P.K., Ponglux D., and Watanabe K. Gen. Pharmacol. 33 (1999) 73
9. Takayama H., Ishikawa H., Kitajima M., and Aimi N. J. Med. Chem. 45 (2002) 1949
10. Watanabe K., Yano S., Horie S., and Yamamoto L.T. Life Sci. 60 (1997) 933
11. Tsuchiya S., Miyashita S., Yamamoto M., Horie S., Sakai S.I., Aimi N., Takayama H., and Watanabe K. Euro. J. Pharmacol. 443 (2002) 185
12. Matsumoto K., Horie S., Takayama H., Ishikawa H., Aimi N., Ponglux D., Murayama T., and Watanabe K. Life Sci. 78 (2005) 187
13. Assanangkornchai S., Muekthong A., Sam-Angsri N., and Pattanasattayawong U. Subst. Use Misuse 45 (2007) 2145
14. Houghton P.J., Ikram A.L., and Saidb M. Phytochemistry 30 (1991) 347
15. Ponglux D., Wongseripipatana S., Takayama H., Kikuchi M., Kurihara M., Kitajima M., Aimi N., and Sakai S. Planta Med. 60 (1994) 580
16. Janchawee B., Keawpradub N., Chittrakarn S., Prasettho S., Wararatananurak P., and Sawangjareon K. Biomed. Chromatogr. 21 (2007) 176
17. Guidance for Industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM), May 2001 BP.
18. Khmel'nitskii R.A. Chem. Heterocyc. Compd. 10 3 (1974) 253
19. Concheiro M., De Castro A., Quintela O., Cruz A., and Lopez-Rivadulla M. J. Anal. Toxicol. 31 (2007) 573